ethyl 4-(2-methoxyphenyl)-4-oxobutyrate, 97.0%, 1g

BENZAMIDE, N-CYCLOPROPYL-4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-, 95.0%, 1g

Boc-(S)-3-Amino-3-phenylpropanal, 95.0%, 250mg

C-(4-Isopropyl-[1,2,3]thiadiazol-5-yl)-methylamine hydrochloride, 95.0%, 1g

N-(4-Hydroxycyclohexyl)methanesulfonamide, 95.0%, 1g

Sachet d'homogénéisation Whirl-Pak® avec zone d'étiquetage, 1650 ml, 190 mm, Hauteur, 300 mm, 500 pièce(s)

Acid Red 112 [for Biochemical Research]>85.0%(HPLC)(N)1g

(1-imidazo[2,1-b][1,3]thiazol-6-ylethyl)amine dihydrochloride, 95.0%, 250mg

Methyl 3,5-Dihydroxy-4-methoxybenzoate>98.0%(GC)5g

tert-Butyl (4-fluorophenyl)carbamate, 97%, 25g

Hexahydro-pyrrolo[1,2-a]pyrazin-6-one, 95.0%, 5g

Pâte PTFE, 10 g

3-Amino-6-bromo-2-chloropyridine>98.0%(GC)1g